|
1
|
Gaikwad SM and Ray P: Non-invasive imaging
of PI3K/Akt/mTOR signalling in cancer. Am J Nucl Med Mol Imaging.
2:418–431. 2012.PubMed/NCBI
|
|
2
|
Xu HY, Chen ZW, Hou JC, Du FX and Liu JC:
Jolkinolide B induces apoptosis in MCF-7 cells through inhibition
of the PI3K/Akt/mTOR signaling pathway. Oncol Rep. 29:212–8.
2013.PubMed/NCBI
|
|
3
|
Slomovitz BM and Coleman RL: The
PI3K/AKT/mTOR pathway as a therapeutic target in endometrial
cancer. Clin Cancer Res. 18:5856–5864. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim H, Choi JA, Park GS and Kim JH: BLT2
up-regulates interleukin-8 production and promotes the invasiveness
of breast cancer cells. PLoS One. 7:e491862012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bao R, Christova T, Song S, Angers S, Yan
X and Attisano L: Inhibition of tankyrases induces Axin
stabilization and blocks Wnt signalling in breast cancer cells.
PLoS One. 7:e486702012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu C, Zhang Y, Xu H, Zhang R, Li H, Lu P
and Jin F: Girdin protein: a new potential distant metastasis
predictor of breast cancer. Med Oncol. 29:1554–1560. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mittal Y, Pavlova Y, Garcia-Marcos M and
Ghosh P: Src homology domain 2-containing protein-tyrosine
phosphatase-1 (SHP-1) binds and dephosphorylates
G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and
attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt
signaling pathway. J Biol Chem. 286:32404–32415. 2011. View Article : Google Scholar
|
|
8
|
Jiang P, Enomoto A, Jijiwa M, Kato T,
Hasegawa T, Ishida M, Sato T, Asai N, Murakumo Y and Takahashi M:
An actin-binding protein Girdin regulates the motility of breast
cancer cells. Cancer Res. 68:1310–1318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghosh P, Garcia-Marcos M and Farquhar MG:
GIV/Girdin is a rheostat that fine-tunes growth factor signals
during tumor progression. Cell Adh Migr. 5:237–248. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu D, Xu H, Ren Y, Liu C, Wang X, Zhang H
and Lu P: Cancer stem cell-related gene periostin: a novel
prognostic marker for breast cancer. PLoS One. 7:e466702012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Chen B, Zhu J, Zhang R, Yao F, Jin
F, Xu H and Lu P: Clinical implications for nestin protein
expression in breast cancer. Cancer Sci. 101:815–819. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ling Y, Jiang P, Cui SP, Ren YL, Zhu SN,
Yang JP, Du J, Zhang Y, Liu JY and Zhang B: Clinical implications
for girdin protein expression in breast cancer. Cancer Invest.
29:405–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Fu L, Gu F and Ma YJ: A new
protein Girdin in tumor metastasis. Chin Med J (Engl).
123:1786–1788. 2010.PubMed/NCBI
|
|
14
|
Dunkel Y, Ong A, Notani D, Mittal Y, Lam
M, Mi X and Ghosh P: STAT3 upregulates GIV/Girdin expression, and
GIV enhances STAT3 activation in a positive feedback loop during
wound healing and tumor invasion/metastasis. J Biol Chem.
287:41667–41683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu C, Xue H, Lu Y and Chi B: Stem cell
gene Girdin: a potential early liver metastasis predictor of
colorectal cancer. Mol Biol Rep. 39:8717–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Natsume A, Kato T, Kinjo S, Enomoto A,
Toda H, Shimato S, Ohka F, Motomura K, Kondo Y, Miyata T, Takahashi
M and Wakabayashi T: Girdin maintains the stemness of glioblastoma
stem cells. Oncogene. 31:2715–2724. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghosh P, Garcia-Marcos M and Farquhar MG:
GIV/Girdin is a rheostat that fine-tunes growth factor signals
during tumor progression. Cell Adh Migr. 5:237–248. 2011.
View Article : Google Scholar : PubMed/NCBI
|
